{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:48:14Z","timestamp":1758120494337,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"State Administration of Traditional Chinese Medicine Industry Specialty","award":["No.201407001-4"],"award-info":[{"award-number":["No.201407001-4"]}]},{"DOI":"10.13039\/501100014207","name":"National Public Health Grand Research Foundation","doi-asserted-by":"crossref","award":["No.201202017"],"award-info":[{"award-number":["No.201202017"]}],"id":[{"id":"10.13039\/501100014207","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institute","award":["No. JX10231801"],"award-info":[{"award-number":["No. JX10231801"]}]},{"name":"Project Funded by Jiangsu Provincial Special Program of Medical Science","award":["No. BL2014086"],"award-info":[{"award-number":["No. BL2014086"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00277-020-03926-6","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T06:03:23Z","timestamp":1579673003000},"page":"443-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective"],"prefix":"10.1007","volume":"99","author":[{"given":"Xiaoqing","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruinan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-5897","authenticated-orcid":false,"given":"Guangsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"issue":"4","key":"3926_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","volume":"142","author":"K Sawada","year":"2008","unstructured":"Sawada K, Fujishima N, Hirokawa M (2008) Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 142(4):505\u2013514","journal-title":"Br J Haematol"},{"issue":"21","key":"3926_CR2","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","volume":"128","author":"RT Means Jr","year":"2016","unstructured":"Means RT Jr (2016) Pure red cell aplasia. Blood 128(21):2504\u20132509","journal-title":"Blood"},{"issue":"1","key":"3926_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1365-2141.1991.tb04392.x","volume":"78","author":"RT Means Jr","year":"1991","unstructured":"Means RT Jr, Dessypris EN, Krantz SB (1991) Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical response. Br J Haematol 78(1):114\u2013119","journal-title":"Br J Haematol"},{"key":"3926_CR4","volume-title":"Pure red cell aplasia","author":"EN Dessypris","year":"1988","unstructured":"Dessypris EN (1988) Pure red cell aplasia. Johns Hopkins University Press, Baltimore"},{"key":"3926_CR5","first-page":"1421","volume-title":"Wintrobe\u2019s clinical hematology","author":"EN Dessypris","year":"2004","unstructured":"Dessypris EN, Lipton JM (2004) Red cell aplasia. In: Wintrobe\u2019s clinical hematology, 11th edn. Lippincott Williams &Wilkins, Philadelphia, pp 1421\u20131427","edition":"11"},{"issue":"2","key":"3926_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.hoc.2009.01.009","volume":"23","author":"K Sawada","year":"2009","unstructured":"Sawada K, Hirokawa M, Fujishima N (2009) Diagnosis and management of acquired pure red cell aplasia. Hematol Oncol Clin North Am 23(2):249\u2013259","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"3926_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12185-018-2446-y","volume":"108","author":"X Wu","year":"2018","unstructured":"Wu X, Wang S, Lu X, Shen W, Qiao C, Wu Y, Lu R, Wang S, Zhang J, Hong M, Zhu Y, Li J, He G (2018) Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center. Int J Hematol 108(2):123\u2013129","journal-title":"Int J Hematol"},{"issue":"2","key":"3926_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3324\/haematol.2017.175810","volume":"103","author":"SK Balasubramanian","year":"2018","unstructured":"Balasubramanian SK, Sadaps M, Thota S, Aly M, Przychodzen BP, Hirsch CM, Visconte V, Radivoyevitch T, Maciejewski JP (2018) Rational management approach to pure red cell aplasia. Haematologica 103(2):221\u2013230","journal-title":"Haematologica"},{"issue":"4","key":"3926_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1600-0609.1997.tb00978.x","volume":"59","author":"S Mamiya","year":"1997","unstructured":"Mamiya S, Itoh T, Miura AB (1997) Acquired pure red cell aplasia in Japan. Eur J Haematol 59(4):199\u2013205","journal-title":"Eur J Haematol"},{"issue":"1","key":"3926_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3324\/haematol.11655","volume":"93","author":"M Hirokawa","year":"2008","unstructured":"Hirokawa M, Sawada K, Fujishima N, Nakao S, Urabe A, Dan K, Fujisawa S, Yonemura Y, Kawano F, Omine M, Ozawa K, PRCA Collaborative Study Group (2008) Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group. Haematologica 93(1):27\u201333","journal-title":"Haematologica"},{"issue":"3","key":"3926_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s002770050151","volume":"72","author":"YL Kwong","year":"1996","unstructured":"Kwong YL, Wong KF, Liang RH, Chu YC, Chan LC, Chan TK (1996) Pure red cell aplasia: clinical features and treatment results in 16 cases. Ann Hematol 72(3):137\u2013140","journal-title":"Ann Hematol"},{"issue":"8","key":"3926_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3324\/haematol.11192","volume":"92","author":"K Sawada","year":"2007","unstructured":"Sawada K, Hirokawa M, Fujishima N, TeramuraM BM, Dan K, Tsurumi H, Nakao S, Urabe A, Omine M, Ozawa K, PRCA Collaborative Study Group (2007) Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica 92(8):1021\u20131028","journal-title":"Haematologica"},{"issue":"10","key":"3926_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.12871","volume":"93","author":"N. Fujishima","year":"2008","unstructured":"Fujishima N, Sawada K, Hirokawa M, Oshimi K, Sugimoto K, Matsuda A, Teramura M, Karasawa M, Arai A, Yonemura Y, Nakao S, Urabe A, Omine M, Ozawa K, PRCA Collaborative Study Group (2008) Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Haematologica 93(10): 1555\u20131559","journal-title":"Haematologica"},{"issue":"2","key":"3926_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood.V63.2.277.277","volume":"63","author":"DA Clark","year":"1984","unstructured":"Clark DA, Dessypris EN, Krantz SB (1984) Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 63(2):277\u2013286","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03926-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-020-03926-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03926-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:15:44Z","timestamp":1611188144000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-020-03926-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3926"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-03926-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"18 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors. This retrospective study was conducted in compliance with good clinical practice and the ethical principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient included in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}